Pharmacology Pitolisant is approved for treatment of A Tenosynol giant cell tumor B Excessive day time sleepiness in patients with narcolepsy C Polyneuropathy due to transthyretin amyloidosis D Primary myelofibrosis π‘ Explanation Pitolisant is approved for treatment of β Correct Answer: B. Excessive day time sleepiness in patients with narcolepsy